[go: up one dir, main page]

PL353803A1 - Radiopharmaceutical products and their preparation procedure - Google Patents

Radiopharmaceutical products and their preparation procedure

Info

Publication number
PL353803A1
PL353803A1 PL00353803A PL35380300A PL353803A1 PL 353803 A1 PL353803 A1 PL 353803A1 PL 00353803 A PL00353803 A PL 00353803A PL 35380300 A PL35380300 A PL 35380300A PL 353803 A1 PL353803 A1 PL 353803A1
Authority
PL
Poland
Prior art keywords
preparation procedure
radiopharmaceutical products
radiopharmaceutical
products
procedure
Prior art date
Application number
PL00353803A
Other languages
English (en)
Polish (pl)
Inventor
EmmanuelBellande Emmanuel Bellande
PierreJallet Pierre Jallet
BenoitDenizot Benoit Denizot
Original Assignee
Schering Aktiengesellschaftschering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaftschering Aktiengesellschaft filed Critical Schering Aktiengesellschaftschering Aktiengesellschaft
Publication of PL353803A1 publication Critical patent/PL353803A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/06Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL00353803A 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure PL353803A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910970A FR2797769B1 (fr) 1999-09-01 1999-09-01 Produits radiopharmaceutiques et leur procede de preparation
PCT/IB2000/001161 WO2001015746A1 (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure

Publications (1)

Publication Number Publication Date
PL353803A1 true PL353803A1 (en) 2003-12-01

Family

ID=9549465

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353803A PL353803A1 (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure

Country Status (23)

Country Link
EP (1) EP1210127A1 (et)
JP (1) JP2003508455A (et)
KR (1) KR20020040799A (et)
CN (1) CN1371292A (et)
AU (1) AU6463100A (et)
BG (1) BG106438A (et)
BR (1) BR0013729A (et)
CA (1) CA2383517A1 (et)
CZ (1) CZ2002782A3 (et)
EA (1) EA200200307A1 (et)
EE (1) EE200200105A (et)
FR (1) FR2797769B1 (et)
HK (1) HK1044893A1 (et)
HU (1) HUP0202714A2 (et)
IL (1) IL148076A0 (et)
MX (1) MXPA02001923A (et)
NO (1) NO20021001L (et)
NZ (1) NZ517377A (et)
PL (1) PL353803A1 (et)
SK (1) SK2772002A3 (et)
WO (1) WO2001015746A1 (et)
YU (1) YU14202A (et)
ZA (1) ZA200201057B (et)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
FR2919189A1 (fr) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres.
CN102977174B (zh) * 2012-12-19 2015-04-22 北京师范大学 99mTc(CO)3核标记大环多胺三唑环类葡萄糖基配合物及制备方法和应用
PL240772B1 (pl) 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Sposób wytwarzania nanocząstek polimerowych chelatujących izotopy promieniotwórcze do zastosowania w diagnostyce i terapii

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7412164L (sv) * 1974-09-27 1976-03-29 Pharmacia Ab Medel for intravaskuler administrering
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
ES2199226T3 (es) * 1992-09-04 2004-02-16 The General Hospital Corporation Polimeros biocompatibles que contienen mitades diagnosticas o terapeuticas.
US5958372A (en) * 1994-06-28 1999-09-28 Nycomed Imaging As Low viscosity chelating polymers for diagnostic imaging
FR2736834B1 (fr) * 1995-07-17 1997-08-29 Cis Bio Int Produits radiopharmaceutiques a tropisme cardiaque comportant un complexe nitruro d'un metal de transition et ayant une clairance myocardique rapide

Also Published As

Publication number Publication date
NO20021001D0 (no) 2002-02-28
CA2383517A1 (en) 2001-03-08
FR2797769B1 (fr) 2003-07-25
FR2797769A1 (fr) 2001-03-02
IL148076A0 (en) 2002-09-12
NZ517377A (en) 2003-08-29
SK2772002A3 (en) 2002-09-10
WO2001015746A1 (en) 2001-03-08
HK1044893A1 (zh) 2002-11-08
ZA200201057B (en) 2003-07-30
BG106438A (bg) 2002-09-30
MXPA02001923A (es) 2003-07-21
HUP0202714A2 (en) 2002-12-28
EE200200105A (et) 2003-04-15
CZ2002782A3 (cs) 2002-08-14
CN1371292A (zh) 2002-09-25
KR20020040799A (ko) 2002-05-30
JP2003508455A (ja) 2003-03-04
BR0013729A (pt) 2002-05-07
EP1210127A1 (en) 2002-06-05
NO20021001L (no) 2002-04-11
YU14202A (sh) 2004-09-03
AU6463100A (en) 2001-03-26
EA200200307A1 (ru) 2002-08-29

Similar Documents

Publication Publication Date Title
PL353803A1 (en) Radiopharmaceutical products and their preparation procedure
HUP0200898A3 (en) Derivatives of venlafaxine and methods of preparing and using the same
CZ20011518A3 (cs) Farmaceutický prostředek
ZA989505B (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
GB2355194B (en) Coformulation methods and their products
HUP0102585A3 (en) Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
SI1043307T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HRP20020372A2 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
GB9928490D0 (en) Products and processes therefor
GB9802088D0 (en) Pharmaceutical products
ZA982073B (en) Pharmaceutical preparation
IL120554A0 (en) Kombucha products and processes for the preparation thereof
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
GB9814817D0 (en) Meat products and their preparation
HUP0203678A3 (en) Nitro-sulfobenzamide-derivatives, preparation and use thereof
IL148351A0 (en) Therapeutic immune condition compositions and methods
GB9927353D0 (en) Virus preparation and use
GB9929581D0 (en) Comjpositions and their use
HUP0201140A2 (en) 3-deoxy-desmycosin derivatives and their preparation
GB9912059D0 (en) Products and methods
GB9917273D0 (en) Products and methods
GB9914202D0 (en) Products and methods
HUP0103302A3 (en) Polyhydroalkylpyrazine derivatives their preparation and medicines containing them

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)